Plain-English translation of NCT07444047 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing whether a new advanced MRI scanning technique called Quantitative Susceptibility Mapping can help doctors better understand brain changes in older adults with multiple sclerosis. When people over 50 get brain scans, it can be hard to tell whether white spots on the scan are caused by multiple sclerosis, aging, or blood vessel disease — and this confusion can make it difficult to track disease progression. This study adds a short, extra MRI sequence to standard scans to see if it can help doctors figure out what's really causing these brain changes.
As people age, their brain scans become harder to interpret because several different conditions can cause similar-looking spots. This study exists to test whether this advanced imaging technique can help doctors more accurately tell apart multiple sclerosis-related changes from age-related or blood vessel-related changes, which could lead to better disease monitoring and treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll continue your routine clinical MRI scans at your hospital — the only difference is that researchers will add a short extra scanning sequence to create these advanced images. You'll also complete brief assessments of your thinking speed, memory, and physical abilities during your regular clinic visits. The study simply adds this extra imaging and testing to the care you're already receiving, with no additional treatments or medications involved.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Norway